JP2014208676A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014208676A5 JP2014208676A5 JP2014126495A JP2014126495A JP2014208676A5 JP 2014208676 A5 JP2014208676 A5 JP 2014208676A5 JP 2014126495 A JP2014126495 A JP 2014126495A JP 2014126495 A JP2014126495 A JP 2014126495A JP 2014208676 A5 JP2014208676 A5 JP 2014208676A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- formula
- iii
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 BN(*)C*C1N(C**)c2c(*)c(**)c(B=*)c(*)c2[C@@]1(CNC)C=** Chemical compound BN(*)C*C1N(C**)c2c(*)c(**)c(B=*)c(*)c2[C@@]1(CNC)C=** 0.000 description 6
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90647307P | 2007-03-12 | 2007-03-12 | |
| US60/906,473 | 2007-03-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009553626A Division JP5567349B2 (ja) | 2007-03-12 | 2008-03-12 | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016077538A Division JP6231151B2 (ja) | 2007-03-12 | 2016-04-07 | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014208676A JP2014208676A (ja) | 2014-11-06 |
| JP2014208676A5 true JP2014208676A5 (https=) | 2014-12-18 |
| JP5918306B2 JP5918306B2 (ja) | 2016-05-18 |
Family
ID=39759858
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009553626A Active JP5567349B2 (ja) | 2007-03-12 | 2008-03-12 | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
| JP2014126495A Active JP5918306B2 (ja) | 2007-03-12 | 2014-06-19 | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
| JP2016077538A Active JP6231151B2 (ja) | 2007-03-12 | 2016-04-07 | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
| JP2017201937A Active JP6522710B2 (ja) | 2007-03-12 | 2017-10-18 | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
| JP2019082541A Active JP6773837B2 (ja) | 2007-03-12 | 2019-04-24 | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
| JP2020166874A Withdrawn JP2021006559A (ja) | 2007-03-12 | 2020-10-01 | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
| JP2022144080A Pending JP2022180440A (ja) | 2007-03-12 | 2022-09-09 | 置換ヘテロ環縮合ガンマ－カルボリンの合成 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009553626A Active JP5567349B2 (ja) | 2007-03-12 | 2008-03-12 | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016077538A Active JP6231151B2 (ja) | 2007-03-12 | 2016-04-07 | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
| JP2017201937A Active JP6522710B2 (ja) | 2007-03-12 | 2017-10-18 | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
| JP2019082541A Active JP6773837B2 (ja) | 2007-03-12 | 2019-04-24 | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
| JP2020166874A Withdrawn JP2021006559A (ja) | 2007-03-12 | 2020-10-01 | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
| JP2022144080A Pending JP2022180440A (ja) | 2007-03-12 | 2022-09-09 | 置換ヘテロ環縮合ガンマ－カルボリンの合成 |
Country Status (12)
| Country | Link |
|---|---|
| US (11) | US8309722B2 (https=) |
| EP (2) | EP3663294A1 (https=) |
| JP (7) | JP5567349B2 (https=) |
| KR (7) | KR102065319B1 (https=) |
| CN (2) | CN101796051B (https=) |
| AU (5) | AU2008226814C1 (https=) |
| CA (1) | CA2679754C (https=) |
| DK (1) | DK2134710T3 (https=) |
| ES (1) | ES2776889T3 (https=) |
| IN (1) | IN2009DN05670A (https=) |
| MX (3) | MX394214B (https=) |
| WO (1) | WO2008112280A1 (https=) |
Families Citing this family (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102065319B1 (ko) | 2007-03-12 | 2020-01-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치환된 헤테로환 융합 감마-카르볼린 합성 |
| US8716308B2 (en) | 2008-01-11 | 2014-05-06 | Albany Molecular Research, Inc. | (1-azinone)-substituted pyridoindoles |
| JP5611846B2 (ja) * | 2008-03-12 | 2014-10-22 | イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． | 置換ヘテロ環縮合ガンマ−カルボリン類固体 |
| CN105168219B (zh) | 2008-05-27 | 2018-11-20 | 细胞内治疗公司 | 用于睡眠障碍和其他疾病的方法和组合物 |
| US9107696B2 (en) * | 2008-08-06 | 2015-08-18 | Emory University | Method of embryo transfer that eliminates transferred air while hormonally inducing implantation and apparatus |
| CN102227431A (zh) | 2008-09-29 | 2011-10-26 | 雅培制药有限公司 | 吲哚和二氢吲哚衍生物及其应用方法 |
| US9625475B2 (en) | 2008-09-29 | 2017-04-18 | Abbvie Inc. | Indole and indoline derivatives and methods of use thereof |
| WO2011003012A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof |
| US8629158B2 (en) | 2009-07-01 | 2014-01-14 | Albany Molecular Research, Inc. | Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
| US9073925B2 (en) | 2009-07-01 | 2015-07-07 | Albany Molecular Research, Inc. | Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
| US8637501B2 (en) | 2009-07-01 | 2014-01-28 | Albany Molecular Research, Inc. | Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof |
| EP2560676B8 (en) | 2010-04-22 | 2016-10-12 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US8993765B2 (en) | 2010-12-21 | 2015-03-31 | Albany Molecular Research, Inc. | Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof |
| WO2012088038A2 (en) | 2010-12-21 | 2012-06-28 | Albany Molecular Research, Inc. | Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof |
| WO2013155504A1 (en) | 2012-04-14 | 2013-10-17 | Intra-Cellular Therapies, Inc. | Novel methods |
| HUE053159T2 (hu) | 2013-03-15 | 2021-06-28 | Intra Cellular Therapies Inc | Szerves vegyületek |
| IL305990B2 (en) | 2013-12-03 | 2025-12-01 | Intra Cellular Therapies Inc | Long-acting injectable composition comprising polymeric microspheres of heterocycle fused gamma-carboline compounds or a pharmaceutical composition for sustained or delayed release comprising the compounds and their use in the treatment of bipolar disorder i and/or bipolar ii disorder |
| RU2016143091A (ru) | 2014-04-04 | 2018-05-08 | Интра-Селлулар Терапиз, Инк. | Органические соединения |
| MX365969B (es) | 2014-04-04 | 2019-06-21 | Intra Cellular Therapies Inc | Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio. |
| WO2015191554A1 (en) | 2014-06-09 | 2015-12-17 | Intra-Cellular Therapies, Inc. | Compounds and methods of use to treat schizophrenia |
| US10118890B2 (en) | 2014-10-10 | 2018-11-06 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
| WO2016176634A1 (en) * | 2015-04-30 | 2016-11-03 | The Regents Of The University Of Colorado, A Body Corporate | Polycyclic indoline and indolenine compounds |
| CN108883111B (zh) | 2016-01-26 | 2021-10-08 | 细胞内治疗公司 | 有机化合物 |
| PL3407889T3 (pl) | 2016-03-25 | 2021-11-22 | Intra-Cellular Therapies, Inc. | Związki organiczne i ich zastosowanie w leczeniu lub zapobieganiu zaburzeniom ośrodkowego układu nerwowego |
| US11014925B2 (en) | 2016-03-28 | 2021-05-25 | Intra-Cellular Therapies, Inc. | Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide |
| EP3436083A4 (en) | 2016-03-28 | 2019-11-27 | Intra-Cellular Therapies, Inc. | NOVEL COMPOSITIONS AND METHOD |
| JP2019513143A (ja) * | 2016-03-28 | 2019-05-23 | イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． | 新規塩類および結晶 |
| EP4001281A1 (en) | 2016-08-09 | 2022-05-25 | Teva Pharmaceuticals International GmbH | Solid state forms of lumateperone ditosylate salt and preparation thereof |
| WO2018064465A1 (en) | 2016-09-29 | 2018-04-05 | The Regents Of The University Of California | Compounds for increasing neural plasticity |
| US11331316B2 (en) | 2016-10-12 | 2022-05-17 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
| US10906906B2 (en) | 2016-12-29 | 2021-02-02 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US10961245B2 (en) | 2016-12-29 | 2021-03-30 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders |
| IL268970B2 (en) | 2017-03-24 | 2023-12-01 | Intra Cellular Therapies Inc | Oral transmucosal formulations of substituted heterocycle fused gamma carbolines |
| JP2020513023A (ja) | 2017-04-10 | 2020-04-30 | ドクター・レディーズ・ラボラトリーズ・リミテッド | ルマテペロンｐ−トシラートの非晶質形態および固体分散体 |
| JP7224333B2 (ja) | 2017-07-26 | 2023-02-17 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
| JP7223742B2 (ja) | 2017-07-26 | 2023-02-16 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
| CN111107847A (zh) | 2017-09-26 | 2020-05-05 | 细胞内治疗公司 | 新的盐和晶体 |
| US11655251B2 (en) | 2017-11-27 | 2023-05-23 | Egis Gyogyszergyar Zrt. | Method for the production of lumateperone and its salts |
| WO2019178484A1 (en) | 2018-03-16 | 2019-09-19 | Intra-Cellular Therapies, Inc. | Novel methods |
| WO2019183546A1 (en) | 2018-03-23 | 2019-09-26 | Intra-Cellular Therapies, Inc. | Organic compounds |
| AU2019240226B2 (en) | 2018-03-23 | 2024-11-28 | Intra-Cellular Therapies, Inc. | Organic compounds |
| IL321985A (en) | 2018-06-06 | 2025-09-01 | Intra Cellular Therapies Inc | New salts and crystals |
| WO2019237037A1 (en) | 2018-06-08 | 2019-12-12 | Intra-Cellular Therapies, Inc. | Novel methods |
| CA3106447A1 (en) * | 2018-06-11 | 2019-12-19 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines synthesis |
| US11806311B2 (en) | 2018-06-21 | 2023-11-07 | Aquestive Therapeutics, Inc. | System and method for making personalized individual unit doses containing pharmaceutical actives |
| ES2986417T3 (es) | 2018-08-13 | 2024-11-11 | Hoffmann La Roche | Nuevos compuestos heterocíclicos como inhibidores de la monoacilglicerol lipasa |
| EP3843729A4 (en) | 2018-08-29 | 2022-06-01 | Intra-Cellular Therapies, Inc. | NOVEL COMPOSITIONS AND PROCESSES |
| CN112584837A (zh) | 2018-08-31 | 2021-03-30 | 细胞内治疗公司 | 新方法 |
| CA3108558A1 (en) * | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
| JP7637616B2 (ja) | 2018-09-07 | 2025-02-28 | アクエスティブ セラピューティクス インコーポレイテッド | 厳密な活性剤溶解プロファイルを有する口腔用フィルム組成物及び剤形 |
| ES2955037T3 (es) | 2018-11-22 | 2023-11-28 | Hoffmann La Roche | Nuevos compuestos heterocíclicos |
| US20220024924A1 (en) | 2018-11-27 | 2022-01-27 | Teva Czech Industries S.R.O | Solid state forms of lumateperone salts and processes for preparation of lumateperone and salts thereof |
| BR112021011792A2 (pt) | 2018-12-17 | 2021-08-31 | Intra-Cellular Therapies, Inc. | Composto orgânico |
| EP3898580A4 (en) * | 2018-12-17 | 2022-08-10 | Intra-Cellular Therapies, Inc. | SYNTHESIS OF CONDENSED GAMMA-CARBOLINES WITH SUBSTITUTED HETEROCYCLE |
| IL283963B2 (en) * | 2018-12-17 | 2025-01-01 | Intra Cellular Therapies Inc | Synthesis of condensed gamma-carbolines and converted heterocycles |
| WO2020132605A1 (en) | 2018-12-21 | 2020-06-25 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US12195463B2 (en) | 2018-12-21 | 2025-01-14 | Intra-Cellular Therapies, Inc. | Organic compounds |
| CN113784962B (zh) | 2019-02-27 | 2025-04-25 | 加利福尼亚大学董事会 | 用于治疗脑部疾病的氮杂环庚三烯并-吲哚类和其他杂环 |
| JP7673040B2 (ja) | 2019-07-07 | 2025-05-08 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 新規方法 |
| EP4034119A4 (en) | 2019-09-25 | 2023-10-18 | Intra-Cellular Therapies, Inc. | NOVEL METHODS |
| BR112022008294A2 (pt) | 2019-11-01 | 2022-07-26 | Aquestive Therapeutics Inc | Composições de profármaco e métodos de tratamento |
| WO2021097247A1 (en) | 2019-11-14 | 2021-05-20 | Aquestive Therapeutics, Inc. | Multimodal compositions and methods of treatment |
| CN110698474B (zh) * | 2019-11-14 | 2021-11-02 | 福州大学 | 一种α位取代四氢-γ-咔啉类化合物及其制备方法和应用 |
| EP4072554A4 (en) | 2019-12-11 | 2023-12-20 | Intra-Cellular Therapies, Inc. | ORGANIC CONNECTION |
| EP4076461B1 (en) | 2019-12-19 | 2026-01-28 | Intra-Cellular Therapies, Inc. | Lumateperone for use in schizophrenia treatment |
| CN112062767B (zh) * | 2020-10-20 | 2022-03-11 | 杭州科巢生物科技有限公司 | 一种卢美哌隆的制备方法及其中间体 |
| WO2022155544A1 (en) | 2021-01-15 | 2022-07-21 | Aquestive Therapeutics, Inc. | Prodrug compositions and methods of treatment |
| CA3210706A1 (en) | 2021-03-09 | 2022-09-15 | Alexander Mark Schobel | Dosage forms having equivalent biocomparable profiles |
| CN113024554B (zh) * | 2021-03-24 | 2023-03-14 | 上海法默生物科技有限公司 | 一种卢美哌隆中间体的制备方法 |
| CN114105980B (zh) * | 2021-12-13 | 2024-04-16 | 南方科技大学坪山生物医药研究院 | 卢美哌隆中间体化合物的制备方法及卢美哌隆中间体化合物 |
| CN114105985B (zh) * | 2021-12-13 | 2024-04-16 | 南方科技大学坪山生物医药研究院 | 不对称氢化构建卢美哌隆中间体的方法及卢美哌隆中间体 |
| TW202333668A (zh) | 2021-12-15 | 2023-09-01 | 美商德利克斯醫療公司 | 經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途 |
| US12414948B2 (en) | 2022-05-18 | 2025-09-16 | Intra-Cellular Therapies, Inc. | Methods |
| JP2026502895A (ja) | 2022-12-30 | 2026-01-27 | イントラ－セルラー・セラピーズ・インコーポレイテッド | セロトニン５－ｈｔ２ａ受容体に作用する複素環縮合ガンマ－カルボリン |
| EP4665344A1 (en) | 2023-02-17 | 2025-12-24 | Intra-Cellular Therapies, Inc. | Lumateperone and derivatives thereof for modulating the nervous system |
| WO2025223504A1 (zh) * | 2024-04-26 | 2025-10-30 | 浙江奥翔药业股份有限公司 | 卢美哌隆中间体及其制备方法 |
| WO2025240804A1 (en) | 2024-05-16 | 2025-11-20 | Intra-Cellular Therapies, Inc. | Novel compositions, devices and methods |
| WO2025257090A1 (en) | 2024-06-10 | 2025-12-18 | Interquim, S.A. | Process for the preparation of synthesis intermediates of lumateperone and lumateperone analogues |
| WO2026011136A1 (en) | 2024-07-03 | 2026-01-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2026011166A1 (en) | 2024-07-03 | 2026-01-08 | Intra-Cellular Therapies, Inc. | Substituted heterocycles for use in the treatment of diseases involving the 5-ht2a receptor |
| CN119912455B (zh) * | 2025-01-22 | 2025-09-23 | 成都臻拓医药科技有限公司 | 一种卢美哌隆中间体化合物的制备方法 |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US38679A (en) | 1863-05-26 | Improvement in water-elevators | ||
| US471A (en) | 1837-11-20 | Mode of | ||
| US6713A (en) | 1849-09-11 | Hobse-poweb | ||
| US39680A (en) | 1863-08-25 | Improvement in machines for breaking and cleaning flax | ||
| US2490813A (en) * | 1944-11-29 | 1949-12-13 | Standard Oil Co | Continuous process for making aryl amines |
| US3299078A (en) * | 1962-10-01 | 1967-01-17 | Smith Kline French Lab | Pyrido [3', 4': 4, 5] pyrrolo [3, 2, 1-hi] indoles and-[3, 2, 1-ij] quinolines |
| US3813392A (en) * | 1969-06-09 | 1974-05-28 | J Sellstedt | Pyrrolo(1,2,3-alpha epsilon)quinoxalin-2(3h)-ones and related compounds |
| US4238607A (en) * | 1972-06-19 | 1980-12-09 | Endo Laboratories Inc. | Pyridopyrrolo benzheterocycles |
| US3914421A (en) * | 1972-06-19 | 1975-10-21 | Endo Lab | Pyridopyrrolobenzheterocycles for combatting depression |
| US4183936A (en) * | 1972-06-19 | 1980-01-15 | Endo Laboratories, Inc. | Pyridopyrrolobenzheterocycles |
| US4115577A (en) * | 1972-06-19 | 1978-09-19 | Endo Laboratories, Inc. | Pyridopyrrolobenzheterocycles |
| US4219550A (en) * | 1978-11-09 | 1980-08-26 | E. I. Du Pont De Nemours And Company | Cis- and trans- octahydropyridopyrrolobenzheterocycles |
| US4522944A (en) * | 1982-12-23 | 1985-06-11 | Erba Farmitalia | Carboxamido-derivatives of 5H-1,3,4-thiadiazolo[3,2-a]pyrimidines, compositions and use |
| ES2058068T3 (es) * | 1986-03-19 | 1994-11-01 | Kumiai Chemical Industry Co | Derivados de 5h-1,3,4-tiadiazol-(3,2-a)-pirimidin-5-ona y compuestos fungicidas con contenido en dichos derivados. |
| EP0242690B1 (en) * | 1986-04-07 | 1993-06-30 | Kumiai Chemical Industry Co., Ltd. | 5H-1,3,4-Thiadiazolo[3,2-a]pyrimidin-5-one derivatives and agricultural-horticultural fungicide composition containing the same |
| US5576460A (en) * | 1994-07-27 | 1996-11-19 | Massachusetts Institute Of Technology | Preparation of arylamines |
| US5654482A (en) * | 1996-02-29 | 1997-08-05 | Xerox Corporation | Triarylamine processes |
| US5648539A (en) * | 1996-02-29 | 1997-07-15 | Xerox Corporation | Low temperature arylamine processes |
| US5648542A (en) * | 1996-02-29 | 1997-07-15 | Xerox Corporation | Arylamine processes |
| US5847166A (en) | 1996-10-10 | 1998-12-08 | Massachusetts Institute Of Technology | Synthesis of aryl ethers |
| US5705697A (en) * | 1997-01-30 | 1998-01-06 | Xerox Corporation | Arylamine processes |
| US5723671A (en) * | 1997-01-30 | 1998-03-03 | Xerox Corporation | Arylamine processes |
| US5723669A (en) | 1997-01-30 | 1998-03-03 | Xerox Corporation | Arylamine processes |
| US6323366B1 (en) * | 1997-07-29 | 2001-11-27 | Massachusetts Institute Of Technology | Arylamine synthesis |
| GB2328686B (en) * | 1997-08-25 | 2001-09-26 | Sankio Chemical Co Ltd | Method for producing arylamine |
| US6395939B1 (en) * | 1997-10-06 | 2002-05-28 | Massachusetts Institute Of Technology | Diaryl ether condensation reactions |
| WO1999043643A2 (en) | 1998-02-26 | 1999-09-02 | Massachusetts Institute Of Technology | Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes |
| US6235936B1 (en) * | 1998-02-26 | 2001-05-22 | Massachusetts Institute Of Technology | Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates |
| US5902901A (en) * | 1998-05-07 | 1999-05-11 | Xerox Corporation | Arylamine processes |
| US7223879B2 (en) * | 1998-07-10 | 2007-05-29 | Massachusetts Institute Of Technology | Ligands for metals and improved metal-catalyzed processes based thereon |
| US6307087B1 (en) * | 1998-07-10 | 2001-10-23 | Massachusetts Institute Of Technology | Ligands for metals and improved metal-catalyzed processes based thereon |
| EP1097158B1 (en) | 1998-07-10 | 2006-01-25 | Massachusetts Institute Of Technology | Ligands for metals and metal-catalyzed processes |
| US6395916B1 (en) | 1998-07-10 | 2002-05-28 | Massachusetts Institute Of Technology | Ligands for metals and improved metal-catalyzed processes based thereon |
| US20010008942A1 (en) * | 1998-12-08 | 2001-07-19 | Buchwald Stephen L. | Synthesis of aryl ethers |
| PE20010052A1 (es) | 1999-04-23 | 2001-01-27 | Upjohn Co | Compuestos de azepinindol tetraciclico como agonistas o antagonistas del receptor de 5-ht |
| US6407092B1 (en) * | 1999-04-23 | 2002-06-18 | Pharmacia & Upjohn Company | Tetracyclic azepinoindole compounds |
| MXPA01012969A (es) | 1999-06-15 | 2003-10-14 | Bristol Myers Squibb Pharma Co | Gamma-carbolinas fusionadas de heterociclo sustituido. |
| US6713471B1 (en) * | 1999-06-15 | 2004-03-30 | Bristol-Myers Squibb Pharma Company | Substituted heterocycle fused gamma-carbolines |
| US7071186B2 (en) * | 1999-06-15 | 2006-07-04 | Bristol-Myers Squibb Pharma Co. | Substituted heterocycle fused gamma-carbolines |
| US6541639B2 (en) * | 2000-07-26 | 2003-04-01 | Bristol-Myers Squibb Pharma Company | Efficient ligand-mediated Ullmann coupling of anilines and azoles |
| US6849619B2 (en) * | 2000-12-20 | 2005-02-01 | Bristol-Myers Squibb Company | Substituted pyridoindoles as serotonin agonists and antagonists |
| PL366233A1 (en) * | 2000-12-20 | 2005-01-24 | Bristol-Myers Squibb Company | Substituted pyridoindoles as serotonin agonists and antagonists |
| US6759554B2 (en) * | 2001-04-24 | 2004-07-06 | Massachusetts Institute Of Technology | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| US6849640B2 (en) * | 2001-08-08 | 2005-02-01 | Pharmacia & Upjohn Company | Therapeutic 1H-pyrido [4,3-b] indoles |
| KR20050032107A (ko) * | 2002-08-02 | 2005-04-06 | 메사추세츠 인스티튜트 오브 테크놀로지 | 구리를 촉매로 한 탄소-헤테로원자 결합 및 탄소-탄소결합 형성방법 |
| US7223870B2 (en) | 2002-11-01 | 2007-05-29 | Pfizer Inc. | Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction |
| PL377426A1 (pl) | 2002-12-19 | 2006-02-06 | Bristol-Myers Squibb Company | Podstawione tricykliczne gamma-karboliny jako agoniści i antagoniści receptora serotoninowego |
| JP2005259113A (ja) | 2004-02-12 | 2005-09-22 | Ricoh Co Ltd | プロセス編集装置、プロセス管理装置、プロセス編集プログラム、プロセス管理プログラム、記録媒体、プロセス編集方法及びプロセス管理方法 |
| US7592454B2 (en) * | 2004-04-14 | 2009-09-22 | Bristol-Myers Squibb Company | Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists |
| WO2006063709A1 (en) * | 2004-12-15 | 2006-06-22 | F.Hoffmann-La Roche Ag | Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer’s disease |
| KR102065319B1 (ko) * | 2007-03-12 | 2020-01-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치환된 헤테로환 융합 감마-카르볼린 합성 |
| JP5611846B2 (ja) | 2008-03-12 | 2014-10-22 | イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． | 置換ヘテロ環縮合ガンマ−カルボリン類固体 |
| CN105168219B (zh) | 2008-05-27 | 2018-11-20 | 细胞内治疗公司 | 用于睡眠障碍和其他疾病的方法和组合物 |
| US8309772B2 (en) | 2008-07-31 | 2012-11-13 | Celanese International Corporation | Tunable catalyst gas phase hydrogenation of carboxylic acids |
| EP2560676B8 (en) * | 2010-04-22 | 2016-10-12 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2013155504A1 (en) | 2012-04-14 | 2013-10-17 | Intra-Cellular Therapies, Inc. | Novel methods |
| HUE053159T2 (hu) | 2013-03-15 | 2021-06-28 | Intra Cellular Therapies Inc | Szerves vegyületek |
| IL305990B2 (en) | 2013-12-03 | 2025-12-01 | Intra Cellular Therapies Inc | Long-acting injectable composition comprising polymeric microspheres of heterocycle fused gamma-carboline compounds or a pharmaceutical composition for sustained or delayed release comprising the compounds and their use in the treatment of bipolar disorder i and/or bipolar ii disorder |
| MX365969B (es) | 2014-04-04 | 2019-06-21 | Intra Cellular Therapies Inc | Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio. |
| PL3407889T3 (pl) | 2016-03-25 | 2021-11-22 | Intra-Cellular Therapies, Inc. | Związki organiczne i ich zastosowanie w leczeniu lub zapobieganiu zaburzeniom ośrodkowego układu nerwowego |
| US11655251B2 (en) | 2017-11-27 | 2023-05-23 | Egis Gyogyszergyar Zrt. | Method for the production of lumateperone and its salts |
-
2008
- 2008-03-12 KR KR1020197019369A patent/KR102065319B1/ko active Active
- 2008-03-12 MX MX2020001497A patent/MX394214B/es unknown
- 2008-03-12 KR KR1020217009724A patent/KR102372149B1/ko active Active
- 2008-03-12 ES ES08742074T patent/ES2776889T3/es active Active
- 2008-03-12 KR KR1020187017827A patent/KR101999300B1/ko active Active
- 2008-03-12 AU AU2008226814A patent/AU2008226814C1/en active Active
- 2008-03-12 KR KR1020157033684A patent/KR101981840B1/ko active Active
- 2008-03-12 IN IN5670DEN2009 patent/IN2009DN05670A/en unknown
- 2008-03-12 JP JP2009553626A patent/JP5567349B2/ja active Active
- 2008-03-12 KR KR1020197013610A patent/KR102107954B1/ko active Active
- 2008-03-12 EP EP20153727.1A patent/EP3663294A1/en active Pending
- 2008-03-12 CN CN2008800157710A patent/CN101796051B/zh active Active
- 2008-03-12 MX MX2009009773A patent/MX2009009773A/es active IP Right Grant
- 2008-03-12 US US12/531,016 patent/US8309722B2/en active Active
- 2008-03-12 CA CA2679754A patent/CA2679754C/en active Active
- 2008-03-12 KR KR1020207012082A patent/KR102238390B1/ko active Active
- 2008-03-12 DK DK08742074.1T patent/DK2134710T3/da active
- 2008-03-12 CN CN201310464631.4A patent/CN103626766B/zh active Active
- 2008-03-12 EP EP08742074.1A patent/EP2134710B1/en active Active
- 2008-03-12 KR KR1020097019338A patent/KR101805914B1/ko active Active
- 2008-03-12 WO PCT/US2008/003340 patent/WO2008112280A1/en not_active Ceased
-
2009
- 2009-09-11 MX MX2022008904A patent/MX2022008904A/es unknown
-
2012
- 2012-08-23 US US13/593,097 patent/US8779139B2/en active Active
-
2014
- 2014-06-19 JP JP2014126495A patent/JP5918306B2/ja active Active
- 2014-06-26 AU AU2014203483A patent/AU2014203483B2/en active Active
- 2014-07-03 US US14/323,545 patent/US9315504B2/en active Active
-
2016
- 2016-03-10 US US15/066,962 patent/US9751883B2/en active Active
- 2016-04-07 JP JP2016077538A patent/JP6231151B2/ja active Active
- 2016-09-27 AU AU2016234905A patent/AU2016234905B2/en active Active
-
2017
- 2017-07-26 US US15/660,762 patent/US10221176B2/en active Active
- 2017-10-18 JP JP2017201937A patent/JP6522710B2/ja active Active
-
2018
- 2018-03-14 AU AU2018201818A patent/AU2018201818B2/en active Active
-
2019
- 2019-01-10 US US16/244,796 patent/US10597395B2/en active Active
- 2019-04-24 JP JP2019082541A patent/JP6773837B2/ja active Active
- 2019-06-12 US US16/439,361 patent/US10464938B2/en active Active
- 2019-09-10 AU AU2019229334A patent/AU2019229334B2/en active Active
- 2019-10-07 US US16/594,603 patent/US11407751B2/en active Active
- 2019-12-12 US US16/711,790 patent/US11066407B2/en active Active
-
2020
- 2020-10-01 JP JP2020166874A patent/JP2021006559A/ja not_active Withdrawn
-
2022
- 2022-06-24 US US17/808,836 patent/US12139490B2/en active Active
- 2022-09-09 JP JP2022144080A patent/JP2022180440A/ja active Pending
-
2024
- 2024-10-03 US US18/905,607 patent/US20250101022A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014208676A5 (https=) | ||
| CA2612612C (en) | Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds | |
| CN1038681C (zh) | 三唑衍生物的制备方法 | |
| JP2021505579A5 (https=) | ||
| JP2018522012A5 (https=) | ||
| JP2012505191A5 (https=) | ||
| DK148960B (da) | Analogifremgangsmaade til fremstilling af n-(4-piperidinyl)-n-phenyl-carbamoyl-derivater | |
| JP2009533369A5 (https=) | ||
| JP2015518892A5 (https=) | ||
| HRP20220510T1 (hr) | Postupci za pripravu (1-(3-fluoro-2-(trifluorometil)izonikotinil) piperidin-4-ona) | |
| NO20063748L (no) | Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer | |
| JP2016516696A5 (https=) | ||
| RU2016110024A (ru) | Некоторые химические соединения, композиции и способы | |
| JP2006508976A5 (ja) | ３−アミノ−ピペリジン誘導体及び製造法 | |
| AR041360A1 (es) | Proceso para la preparacion de valsartan | |
| JP2015524409A5 (https=) | ||
| JP2005527627A5 (https=) | ||
| CN101044138A (zh) | 吲唑化合物的制备方法 | |
| RU2015106856A (ru) | Способ получения производных пиразолкарбоновой кислоты | |
| JP2010520214A5 (https=) | ||
| JP2009536618A5 (https=) | ||
| JP2018522018A5 (https=) | ||
| RU2012116208A (ru) | Способ получения n-ацилбифенилаланина | |
| JP2010534246A5 (https=) | ||
| JP2014522385A5 (https=) |